87 related articles for article (PubMed ID: 7561358)
21. Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.
Peest D; Hölscher R; Weber R; Leo R; Deicher H
Clin Exp Immunol; 1989 Feb; 75(2):252-7. PubMed ID: 2784737
[TBL] [Abstract][Full Text] [Related]
22. Cytokines and signal transduction.
Hideshima T; Podar K; Chauhan D; Anderson KC
Best Pract Res Clin Haematol; 2005; 18(4):509-24. PubMed ID: 16026734
[TBL] [Abstract][Full Text] [Related]
23. [Pathogenesis of multiple myeloma].
Sakai A
Nihon Rinsho; 2015 Jan; 73(1):2-6. PubMed ID: 25626295
[No Abstract] [Full Text] [Related]
24. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
25. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
27. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
28. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
[TBL] [Abstract][Full Text] [Related]
29. Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.
Aikawa S; Hatta Y; Tanaka M; Kaneita Y; Yasukawa K; Sawada U; Horie T; Tsuboi I; Aizawa S
Int J Oncol; 2003 Mar; 22(3):631-7. PubMed ID: 12579318
[TBL] [Abstract][Full Text] [Related]
30. Biology and treatment of multiple myeloma.
Tosi P; Gamberi B; Giuliani N
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):81-6. PubMed ID: 16399590
[TBL] [Abstract][Full Text] [Related]
31. Interaction between a murine myeloma cell line and bone marrow stromal cells.
Bradley TR; Kriegler AB; Verschoor SM; Tzelepis SM; Cooper IA
Exp Hematol; 1996 Feb; 24(2):307-9. PubMed ID: 8641357
[TBL] [Abstract][Full Text] [Related]
32. [Immunoglobulin producing mechanism and their abnormalities].
Hamano T
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1050-4. PubMed ID: 7561357
[No Abstract] [Full Text] [Related]
33. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
Barton BE; Murphy TF
Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
[TBL] [Abstract][Full Text] [Related]
34. Myeloma colony growth and patient status: colony growth in plasma cell leukemia and suppressive effect of leukemic cells.
Otsuka T; Okamura S; Niho Y; Yanase T
Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):143-9. PubMed ID: 6741428
[No Abstract] [Full Text] [Related]
35. [gp-130 related cytokines in mechanisms of myeloma cell growth].
Fukutoku M; Shimizu S
Rinsho Ketsueki; 1997 Apr; 38(4):262-5. PubMed ID: 9146047
[No Abstract] [Full Text] [Related]
36. [Physiopathology, diagnosis and therapy in multiple myeloma (discussion)].
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1132-49. PubMed ID: 7561372
[No Abstract] [Full Text] [Related]
37. Role of cytokines in multiple myeloma.
Anderson KC; Lust JA
Semin Hematol; 1999 Jan; 36(1 Suppl 3):14-20. PubMed ID: 9989484
[TBL] [Abstract][Full Text] [Related]
38. Morphological and functional studies of myeloma cells with haemophagocytosis.
Nakazawa M; Ninomiya H; Abe T; Mori N; Kojima M
Nihon Ketsueki Gakkai Zasshi; 1986 Jul; 49(4):938-49. PubMed ID: 3490106
[No Abstract] [Full Text] [Related]
39. Dual regulatory effects of monocytes-macrophages on the proliferation of myeloma cells.
Shimizu S; Yoshioka R; Sugai S; Takiguchi T; Konda S
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1550-7. PubMed ID: 2470229
[No Abstract] [Full Text] [Related]
40. [Identification of myeloma-initiating cells and development of their targeting therapy].
Hosen N; Sugiyama H
Rinsho Ketsueki; 2013 Jun; 54(6):505-12. PubMed ID: 23823088
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
